Biodegradable pressure-sensitive adhesives and coatings formulated with lactide-based macromonomers that replace conventional soft monomers, delivering tunable performance and fungal biodegradability across latex and hotmelt formats.
This technology offers a renewable approach to pressure-sensitive adhesives (PSAs) and coatings by substituting lactide-based macromonomers (MMs) for traditional soft monomers such as n-butyl acrylate and 2-ethylhexyl acrylate. The resulting hybrid materials combine acrylic backbones with renewable MM pendant groups, producing adhesives that match or exceed the performance of commercial benchmarks while enabling high or full biodegradation through targeted fungi species. Performance can be tuned by adjusting biomass composition, structure, and MM content, and the underlying chemistry is transferable to a broad range of coating materials beyond adhesives.
The technology has been demonstrated in both latex and thermoplastic pressure-sensitive adhesive formats, with generated adhesives matching or exceeding commercial adhesive performance. Current development is focused on optimizing formulations for specific applications, expanding MM content and structural variations, and identifying fungi species capable of degrading the hybrid adhesive polymers. The approach is positioned for further scale-up and application-specific validation, with strong potential for commercialization in sustainable adhesives and coatings markets.
The University of Minnesota is a flagship, comprehensive public research university spanning multiple campuses, with a large research enterprise and clinical integration. Industry engages through co-located labs on the Twin Cities campuses, access to an academic health system for clinical translation, and pilot and field-testing facilities that speed scale-up. A statewide extension network and outreach centers provide real-world sites and data partnerships across Minnesota, while proximity to a dense medtech and Fortune 500 corridor enables frequent collaboration. Research is supported by competitive federal funding, including NIH, NSF, DOE, USDA, and DoD. A dedicated technology transfer office manages IP, licensing, sponsored research agreements, and startup incubation to speed commercialization.